NYSE:CL - Colgate-Palmolive Stock Price, News, & Analysis

Get Started

$62.00 -0.13 (-0.21 %)

(As of 01/17/2019 04:00 PM ET)

Previous Close$62.13

Today's Range$61.9101 - $62.50

52-Week Range$57.41 - $77.91

Volume3.55 million shs

Average Volume4.33 million shs

Market Capitalization$53.96 billion

P/E Ratio21.60

Dividend Yield2.72%

Beta0.75

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products. It also provides pet nutrition products for everyday nutritional needs; a range of therapeutic products to manage disease conditions; and various products with natural ingredients. The company's principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet, and Hill's Ideal Balance. It markets and sells its oral, personal and home care products to various retail and wholesale customers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers and veterinarians. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Toilet preparations

Sub-IndustryHousehold Products

SectorConsumer Staples

Current SymbolNYSE:CL

Previous Symbol

CUSIP19416210

Webwww.colgate.comen-usenusoc

Phone212-310-2000

Debt

Debt-to-Equity RatioN/A

Current Ratio1.11

Quick Ratio0.77

Price-To-Earnings

Trailing P/E Ratio21.60

Forward P/E Ratio20.95

P/E Growth2.99

Sales & Book Value

Annual Sales$15.45 billion

Price / Sales3.48

Cash Flow$3.4273 per share

Price / Cash Flow18.09

Book Value$0.28 per share

Price / Book221.43

Profitability

EPS (Most Recent Fiscal Year)$2.87

Net Income$2.02 billion

Net Margins13.55%

Return on Equity12,004.60%

Return on Assets20.46%

Miscellaneous

Employees35,900

Outstanding Shares867,320,000

Market Cap$53.96 billion

OptionableOptionable

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive declared a quarterly dividend on Thursday, January 10th. Investors of record on Wednesday, January 23rd will be given a dividend of $0.42 per share on Friday, February 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.71%. The ex-dividend date of this dividend is Tuesday, January 22nd. View Colgate-Palmolive's Dividend History.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive declared that its board has authorized a stock buyback plan on Monday, June 18th 2018, which allows the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to purchase up to 9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its stock is undervalued.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) posted its earnings results on Friday, October, 26th. The company reported $0.72 earnings per share for the quarter, meeting the consensus estimate of $0.72. The business earned $3.85 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. The business's quarterly revenue was down 3.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.73 earnings per share. View Colgate-Palmolive's Earnings History.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, January 25th 2019. View Earnings Estimates for Colgate-Palmolive.

How can I listen to Colgate-Palmolive's earnings call?

Colgate-Palmolive will be holding an earnings conference call on Friday, January 25th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

What price target have analysts set for CL?

16 equities research analysts have issued 1 year price objectives for Colgate-Palmolive's shares. Their predictions range from $54.00 to $79.00. On average, they anticipate Colgate-Palmolive's share price to reach $66.7857 in the next year. This suggests a possible upside of 7.7% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.

What is the consensus analysts' recommendation for Colgate-Palmolive?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:

1. According to Zacks Investment Research, "Colgate is smoothly progressing with its cost-savings program. Notably, the Global Growth and Efficiency Program and Funding the Growth initiative are delivering impressive results. Management approved an expansion and extension of the program through Dec 31, 2019, which will enable it to take advantage of the incremental opportunities while streamlining operations. Further, the company’s meet or beat earnings long track record remains impressive. It also provided a favorable earnings view for 2018. However, the stock has lagged the industry in the past three months. It has a dismal sales trend, missing estimates in 21 of the last 22 quarters. Management anticipates a tough backdrop due to uncertain global markets and slowing category growth worldwide. It expects sales to decline low-single digits in the fourth quarter. Also, the company has been witnessing strained margins for the last few quarters, which is likely to persist going ahead." (1/10/2019)
2. Wells Fargo & Co analysts commented, "We maintain our FY18/FY19 EPS estimates by $3.02/$3.27 and our $64 price target." (7/27/2018)

Has Colgate-Palmolive been receiving favorable news coverage?

News headlines about CL stock have been trending very positive on Thursday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Colgate-Palmolive earned a news sentiment score of 3.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days.

Who are some of Colgate-Palmolive's key competitors?

Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Coty (COTY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Revlon (REV), Mandom (MDOMF), Avon Products (AVP), e.l.f. Beauty (ELF), United-Guardian (UG), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:

Mr. Ian M. Cook, Chairman & CEO (Age 65)
Mr. Noel R. Wallace, Pres & COO (Age 54)
Mr. Dennis J. Hickey, Vice Chairman (Age 70)
Mr. Franck J. Moison, Vice Chairman (Age 64)
Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 58)

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by many different of retail and institutional investors. Top institutional investors include Confluence Investment Management LLC (0.18%), Packer & Co Ltd (0.14%), LGT Capital Partners LTD. (0.11%), Gateway Investment Advisers LLC (0.09%), BTIM Corp. (0.07%) and Douglass Winthrop Advisors LLC (0.06%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

Which major investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Gulf International Bank UK Ltd, Bath Savings Trust Co, Wendell David Associates Inc., Boston Advisors LLC, Bristlecone Advisors LLC, DNB Asset Management AS, Personal Capital Advisors Corp and Private Asset Management Inc.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin and Philip G Shotts. View Insider Buying and Selling for Colgate-Palmolive.

Which major investors are buying Colgate-Palmolive stock?

CL stock was acquired by a variety of institutional investors in the last quarter, including Packer & Co Ltd, USS Investment Management Ltd, Rockland Trust Co., Bright Rock Capital Management LLC, Virtu Financial LLC, Oakbrook Investments LLC, Deane Retirement Strategies Inc. and Confluence Investment Management LLC. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $62.00.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $53.96 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is http://www.colgate.com/en-us/en/us/oc.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)

Community Ranking:		1.6 out of 5 ()
Outperform Votes:		367 (Vote Outperform)
Underperform Votes:		758 (Vote Underperform)
Total Votes:		1,125

MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 1/17/2019 by MarketBeat.com Staff